Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03897088
Brief Title: Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasi

First Submitted : March 27, 2019
First Submitted that Met QC Criteria : March 28, 2019
First Posted : April 1, 2019

Last Update Submitted that Met QC Criteria : February 10, 2021
Last Update Posted : February 11, 2021